<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Coculture of primary CAFs with M6-Hh cells was sufficient to induce the expression of the Hh target genes 
 <italic>Ptch2</italic>, 
 <italic>Gli1</italic>, and 
 <italic>Hhip</italic> in CAFs (Supplementary Fig. 
 <xref rid="MOESM1" ref-type="media">3a, b</xref>) with concomitant upregulation of CSC markers 
 <italic>Id3</italic>, 
 <italic> Sox10</italic>, 
 <italic>Itgb3</italic>, and 
 <italic>Krt6b</italic> in M6-Hh cells (Supplementary Fig. 
 <xref rid="MOESM1" ref-type="media">3a, c</xref>). Importantly, this stromal-epithelial malignant crosstalk was blocked by SMOi (Fig. 
 <xref rid="Fig3" ref-type="fig">3a</xref>, Supplementary Fig. 
 <xref rid="MOESM1" ref-type="media">3b, c</xref>). These data allow us to conclude that Hh signaling occurs solely in a paracrine manner in this murine model of TNBC and that CAFs are the therapeutic target of SMOi in TNBC.
</p>
